IFP Advisors Inc Acquires New Position in Semler Scientific, Inc. (NASDAQ:SMLR)

IFP Advisors Inc bought a new position in shares of Semler Scientific, Inc. (NASDAQ:SMLR) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 998 shares of the company’s stock, valued at approximately $54,000.

Several other large investors have also recently modified their holdings of SMLR. Global Retirement Partners LLC boosted its holdings in Semler Scientific by 62.5% in the 4th quarter. Global Retirement Partners LLC now owns 1,300 shares of the company’s stock worth $70,000 after buying an additional 500 shares during the period. Quest Partners LLC boosted its holdings in shares of Semler Scientific by 48.0% in the third quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock worth $59,000 after acquiring an additional 817 shares during the period. US Bancorp DE grew its position in shares of Semler Scientific by 60.8% in the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after purchasing an additional 1,158 shares in the last quarter. Sanctuary Advisors LLC bought a new stake in shares of Semler Scientific during the 3rd quarter valued at $104,000. Finally, Veery Capital LLC bought a new position in Semler Scientific in the 4th quarter worth about $324,000. Hedge funds and other institutional investors own 49.37% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Lake Street Capital upped their price target on Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a research report on Friday, January 24th.

Semler Scientific Price Performance

NASDAQ SMLR opened at $36.10 on Friday. The company’s 50 day simple moving average is $52.19 and its two-hundred day simple moving average is $43.56. Semler Scientific, Inc. has a 1 year low of $20.88 and a 1 year high of $81.56. The stock has a market capitalization of $346.45 million, a PE ratio of 7.35 and a beta of 1.33.

Semler Scientific (NASDAQ:SMLR) last issued its quarterly earnings data on Tuesday, February 18th. The company reported $3.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $3.21. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%. The company had revenue of $12.41 million for the quarter.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.